The Boston Science Harbor Base has been completed and opened, achieving "independent production" in China
qyhyu
发表于 前天 19:18
3072
0
0
On October 15th, the first production and manufacturing base of Boston Scientific China, the Boston Scientific Port Base, was completed and opened, focusing on the production of medical consumables and equipment, enabling the company to achieve "independent production" in China.
It is reported that the Boston Scientific Lingang factory is equipped with leading laboratories in the medical technology industry, advanced production workshops and warehouses, as well as clean rooms that meet both Chinese and international standards. Its overall design integrates new technologies and experiences from Boston Scientific's factories around the world, with the goal of building it into a smart factory with first-class quality and excellent technology worldwide.
Boston Scientific introduces that as an important part of the company's comprehensive localization strategy layout in China, the base will focus on the production of medical consumables and equipment in the future. This will enable the company to achieve "independent production" in China, which will help build a localization strategy layout covering all links of the entire industry chain, including trade, production, research and development, investment, and services, and provide more diversified innovative medical products for Chinese patients.
Zhang Jun, President of Boston Scientific Greater China, stated that the completion of the Lingang factory is an important milestone for Boston Scientific's development in China. The company will rely on the advantages of Lingang to build a more agile and resilient supply chain, in order to respond to local medical and patient needs more timely, quickly, and stably. In the future, the company will continue to increase investment in China, actively cooperate with local suppliers, promote the transformation and upgrading of the local industrial chain with globally unified quality standards, and provide urgently needed innovative medical products for Chinese doctors and patients with high incidence diseases with new quality productivity.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- FedEx makes strategic investment in independent e-commerce warehousing and distribution service technology company
- Tianjing Biotechnology grants Sanofi the rights to Yulelimab in China with a down payment of 250 million yuan
- Sanofi's targeted therapy drug for chronic obstructive pulmonary disease, Dabitou, has been approved in China
- The targeted therapy drug for chronic obstructive pulmonary disease, Dabitou, has been approved in China
- Sanofi: Targeted therapy drug for chronic obstructive pulmonary disease (COPD), Dabitou, approved in China
- General Motors Q3 sold over 420000 vehicles in China, surpassing gasoline powered vehicles for the first time in new energy vehicles
- Has the 'fixed price' policy been effective? General Motors' sales in China increased by 14.3% month on month in the third quarter, and SAIC GM's orders for certain models were overstocked
- Hyatt Hotels and China Resources Land establish a joint venture for light asset expansion, continuing to expand into the Chinese market
- The first production and manufacturing base of Boston Scientific China has opened
- The first production and manufacturing base of Boston Scientific China has opened in Lingang, Shanghai
-
10月15日、石油株の米株価は下落し、シェブロン、エクソンモービル、コフィー石油、西側石油はいずれも2%以上下落した。
- 什么大师特
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
自動車企業の花形マーケティングが再び話題になっている。極クリプトン知能科学技術の楊大成副総裁は10月11日、ソーシャルメディアに「極クリプトンMIXで鍋を食べる」という動画を投稿した。動画では、極クリプトン ...
- 套顿各爱了
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
【アップルの4割引携帯電話特許が国内にも企業立地を暴露】今年、ファーウェイが世界に先駆けて3割引携帯電話を発表した後、アップルが米国で申請した4割引携帯電話の特許が明らかになり、スマートフォンがさらに多 ...
- 愿为素心人
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
【淡水河谷の2024年第3四半期の鉄鉱石生産量が2018年第4四半期以来の高値を更新】このほど、淡水河谷は2024年第3四半期の生産販売量報告書を発表した。同社の第3四半期の鉄鉱石生産量は前年同期比470万トン増の9100 ...
- SNT
- 昨天 11:53
- 支持
- 反对
- 回复
- 收藏